Gadoteridol 70436-0121-34
- Manufacturer
- Slate Run Pharmaceuticals, Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- February 20, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA218749
Need to source Gadoteridol? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Gadoteridol | 279.3 mg/mL |
Drug Class
Paramagnetic Contrast Agent [EPC]Magnetic Resonance Contrast Activity [MoA]Paramagnetic Contrast Agent [EPC]
Selected Package
70436-0121-34Selected5 VIAL, SINGLE-DOSE in 1 CARTON (70436-121-34) / 15 mL in 1 VIAL, SINGLE-DOSE
Other packages for this product(3)
5 VIAL, SINGLE-DOSE in 1 CARTON (70436-121-31) / 5 mL in 1 VIAL, SINGLE-DOSE
5 VIAL, SINGLE-DOSE in 1 CARTON (70436-121-33) / 10 mL in 1 VIAL, SINGLE-DOSE
5 VIAL, SINGLE-DOSE in 1 CARTON (70436-121-35) / 20 mL in 1 VIAL, SINGLE-DOSE